Price, D., Henley, W., Delfini Cançado, J. E., Fabbri, L. M., Kerstjens, H. A., Papi, A., . . . Georges, G. (2024). Risk of Pneumonia in Patients with COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate versus Patients Initiating LABD Without ICS. Taylor and Francis Group.
Citação norma ChicagoPrice, David, et al. Risk of Pneumonia in Patients With COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate Versus Patients Initiating LABD Without ICS. Taylor and Francis Group, 2024.
Citação norma MLAPrice, David, et al. Risk of Pneumonia in Patients With COPD Initiating Fixed Dose Inhaled Corticosteroid (ICS) / Long-Acting Bronchodilator (LABD) Formulations Containing Extrafine Beclometasone Dipropionate Versus Patients Initiating LABD Without ICS. Taylor and Francis Group, 2024.